What is Botox? BOTOX® Cosmetic (or Botulinum Toxin Type A) is one of the most popular and widely used anti-aging procedures in use today. It is approved and used in 85 countries for a variety of medical indications, including overactive bladder, muscle stiffness in elbow and wrist, migraines and certain types of eye muscle problems, but is best known in the US for its ability to smooth out, firm up and restore the youthful tone of skin.
www.LookYoungerMD.com® Cosmetic is a purified protein produced by the Clostridium botulinum bacterium. The BOTOX® treatment procedure is a cosmetic elective out-patient, non-surgical, physician-administered injection of purified protein that can temporarily reduce moderate to severe frown lines between the brows. During treatment, very low doses of BOTOX® Cosmetic are administered via a few tiny injections directly into the muscles that cause those stubborn lines. The treatment is usually done in about 10 minutes, and usually minimal recovery time is needed.
It may seem odd to seek BOTOX® Cosmetic injections from a dentist. However, who better than a dentist, someone with a keen understanding of facial structures, to provide you with this service? The dentists at The Smile Centre focus on providing our patients with beautiful, seamless smiles. By natural extension, they are also interested in helping patients look and feel wonderful about the area around their mouth.
When you arrive at your doctor’s office for your BOTOX® treatment, you will first be asked to fill out patient information and other forms. Then you will meet with your doctor or a trained staff member to discuss your expectations for the procedure. At this time, it is important to be honest about any allergies or other conditions that may not make you a good candidate for BOTOX® treatment.
The bacterium can also be found in the intestinal tracts of mammals and fish and in the gills and viscera of crabs and other shellfish. Such naturally occurring instances of Clostridium botulinum bacteria and spores are typically relatively harmless. Problems only usually arise when the spores transform into vegetative cells and the cell population increases to the point where the bacteria begin producing botulinum toxin, the deadly neurotoxin responsible for botulism.
There are limited data on which to base an assessment of the safety of exposure to botulinum toxin (either BTX-A or BTX-B) in human pregnancy. Animal studies of botulinum toxin type A have demonstrated teratogenic risk, however available data from human pregnancies exposed to Clostridium botulinum infection or to botulinum toxin type A do not suggest a significantly increased risk of congenital malformations or spontaneous abortion, although data are too limited to exclude any increase in risk. There are no data available on exposure to botulinum toxin type B on which to base an assessment of the risks following exposure in human pregnancy.